129 related articles for article (PubMed ID: 24381107)
21. IMPACT OF FGFR4 (GLY388ARG) GENE POLYMORPHISM ALONG WITH VISFATIN CYTOKINE AND HIGH MOBILITY GROUP BOX-1 (HMGB1) ON ACUTE CHOLECYSTITIS.
Alfuaadi IH; Altamemi IA
Wiad Lek; 2022; 75(5 pt 2):1242-1247. PubMed ID: 35758438
[TBL] [Abstract][Full Text] [Related]
22. CXCL12 rs18011157 polymorphısm in patients wıth non-Hodgkin's lymphoma: Is it associated with poor outcome?
Pamuk GE; Tozkır H; Uyanık MS; Gurkan H; Duymaz J; Pamuk ON
J Cancer Res Ther; 2018; 14(5):1075-1078. PubMed ID: 30197351
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development.
Naidu R; Har YC; Taib NA
Oncol Res; 2009; 18(2-3):65-71. PubMed ID: 20066896
[TBL] [Abstract][Full Text] [Related]
24. Fibroblast growth factor receptor 4 Gly388 Arg polymorphism is not associated with pre-eclampsia in Turkish women.
Gunes EG; Pinarbasi E
J Obstet Gynaecol Res; 2011 Dec; 37(12):1824-7. PubMed ID: 21827571
[TBL] [Abstract][Full Text] [Related]
25. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
[TBL] [Abstract][Full Text] [Related]
26. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.
Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.
Wei W; You Z; Sun S; Wang Y; Zhang X; Pang D; Jiang Y
Mol Carcinog; 2018 Aug; 57(8):988-996. PubMed ID: 29603419
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 2 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Chen L; Cha Z; Bai J
DNA Cell Biol; 2012 Jul; 31(7):1279-84. PubMed ID: 22472080
[TBL] [Abstract][Full Text] [Related]
29. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
30. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
31. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
[TBL] [Abstract][Full Text] [Related]
32. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
[TBL] [Abstract][Full Text] [Related]
34. Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.
Pamuk GE; Tozkir H; Uyanik MS; Gurkan H; Duymaz J; Pamuk ON
Leuk Lymphoma; 2015; 56(10):2902-7. PubMed ID: 25699652
[TBL] [Abstract][Full Text] [Related]
35. Risk of genome-wide association study-identified genetic variants for non-Hodgkin lymphoma in a Chinese population.
Qiao Y; Zhou Y; Wu C; Zhai K; Han X; Chen J; Tian X; Chang J; Lu Z; Zhang B; Yu D; Yao J; Shi Y; Tan W; Lin D
Carcinogenesis; 2013 Jul; 34(7):1516-9. PubMed ID: 23455380
[TBL] [Abstract][Full Text] [Related]
36. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.
Chen L; Lei Z; Ma X; Huang Q; Zhang X; Zhang Y; Hao P; Yang M; Zhao X; Chen J; Liu G; Zheng T
Sci Rep; 2016 Sep; 6():33604. PubMed ID: 27640814
[TBL] [Abstract][Full Text] [Related]
38. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
[TBL] [Abstract][Full Text] [Related]
39. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
Zhang Y; Chen MB; Zhou XY; Hong XN
PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
[TBL] [Abstract][Full Text] [Related]
40. Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma.
Diao LP; Yu XM; Gao YH; Li Y; Liu HS; Liu LH; Zhou RM; Wang N; Wu LL; Wang SJ
J Cancer Res Clin Oncol; 2009 Nov; 135(11):1473-81. PubMed ID: 19649652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
